Psychemedics Launches Groundbreaking Quartile Reporting for Enhanced Drug Testing Insights

Rhea-AI Summary

Psychemedics has launched a groundbreaking Quartile Reporting feature for hair drug testing, marking an industry-first enhancement. The new feature segments test results into four quartiles – Lower, Median, Upper, and Highest – providing context for drug test results within a 12-month benchmark.

The enhancement allows organizations to see where individual candidate or employee test results rank among other positive reports, enabling more informed decision-making for workplace safety and compliance. CEO Brian Hullinger emphasizes this innovation's role in delivering more reliable and actionable drug testing solutions.

Notable features include enhanced insights for result ranking, real-time analytics for confident decision-making, and data-driven support for hiring and compliance strategies. The Quartile Reporting feature is being offered to all Psychemedics clients at no additional cost, demonstrating the company's commitment to delivering value and advancing industry standards.

Positive

• Launch of innovative drug testing feature at no additional cost to clients
• Enhanced data analytics capabilities for client decision-making
• Competitive advantage as first-to-market with quartile reporting

Negative

• None.

DALLAS, March 03, 2025 (GLOBE NEWSWIRE) -- Psychemedics Corporation, a global leader in hair drug testing, is proud to announce the launch of its innovative Quartile Reporting feature. This industry-first enhancement empowers organizations with unprecedented insights into drug test results, enabling data-driven decision-making and fostering safer, more productive workplaces.

The new Quartile Reporting feature allows clients to see where a candidate’s or employee’s test results fall within a range of positive reports collected over the past 12 months. By segmenting results into four quartiles – Lower, Median, Upper, and Highest – this advanced reporting provides real-time context and benchmarks for substance use trends within the workforce.

“Our mission has always been to provide our clients with the most reliable and actionable drug testing solutions," said Brian Hullinger, Chief Executive Officer and President of Psychemedics. “With Quartile Reporting, we’re bringing a new level of clarity and precision to the industry, enabling organizations to better understand drug test results and make informed decisions that enhance workplace safety and compliance.”

Key Benefits of Quartile Reporting

• Enhanced Insights: Understand where individual results rank among other positives, offering valuable benchmarks for decision-making.
• Real-Time Analytics: Access up-to-date data and trends, empowering clients to act with confidence.
• Data-Driven Decisions: Use detailed context to support hiring, retention, and compliance strategies.
  

A Breakthrough in Workplace Drug Testing

As the drug testing landscape continues to evolve, Psychemedics is leading the way in delivering cutting-edge solutions that address the unique challenges faced by today’s employers. Quartile Reporting is part of Psychemedics’ ongoing efforts to innovate and meet the growing demand for more comprehensive, insightful drug testing data.

This enhancement is available to all Psychemedics clients at no additional cost, underscoring the company’s dedication to delivering exceptional value and driving industry advancement.

“We’re constantly striving to bring our clients tools that improve their programs and set new standards in the industry,” Brian Hullinger added. “Quartile Reporting exemplifies our commitment to innovation and our mission to empower organizations with the insights they need to thrive.”

About Psychemedics 

Psychemedics Corporation is a leading global provider of innovative hair testing for drugs of abuse. With a commitment to accuracy and reliability, the company offers cutting-edge drug testing solutions. Psychemedics Corporation is dedicated to providing valuable insights and maintaining the highest standards in substance abuse testing.

Investor Relations:
Phone: 978-206-8220
Email: InvestorRelations@psychemedics.com 

FAQ

What is Psychemedics' new Quartile Reporting feature for drug testing?

Psychemedics' Quartile Reporting segments drug test results into four quartiles (Lower, Median, Upper, Highest), providing context for results against 12-month benchmarks.

How will PMD's Quartile Reporting benefit employers?

It provides enhanced insights into drug test results, real-time analytics, and data-driven decision support for hiring, retention, and compliance strategies.

Is there an additional cost for PMD's new Quartile Reporting feature?

No, the Quartile Reporting feature is available to all Psychemedics clients at no additional cost.

When did PMD launch its Quartile Reporting feature?

Psychemedics launched the Quartile Reporting feature on March 03, 2025.